PodcastIntel
Sign in Get Started Free
Life Science Connect

Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil

Aug 24, 2026 · 0:56:09
AI Summary
  • Santé Ventures focuses on funding early-stage biotech with clinical data and differentiation.
  • Exploring 'undruggable targets,' IPO market trends, and investor risk shifts.
  • Building biotech companies through a venture creation process is key.

Guests on This Episode

More from Life Science Connect

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Life Science Connect and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →